Presented as part of the Musella Foundations' Brain Tumor Webinar Series. Speaker: Michael Ciesielski, PhD, Chief Executive Officer of MimiVax, LLC Presented on 7/18/23
Hi and thanks for informative presentation. I have gbm that was diagnosed in February 2023. I had surgery followed by radiation and temozolomide for 40 days. I had a good recovery. From July to December 23 i had chemo temozolimide higher doze. But, in decemer 23 i had an mri that a recurrence and doctor prescribed avastin and irinotecan for six sessions each taken every two weeks. Tolerance has been relevatly good. My query is whether is it possible to participate in the these clinical trials after current avastin/ irinotecan?
Can this be used just after a patient starts using Optune or is it limited to patients who just completed radiation? How does someone get accepted to clinical trial?
Hello. Is there any expectation of testing this vaccine in Brazil?
Hi and thanks for informative presentation. I have gbm that was diagnosed in February 2023. I had surgery followed by radiation and temozolomide for 40 days. I had a good recovery. From July to December 23 i had chemo temozolimide higher doze. But, in decemer 23 i had an mri that a recurrence and doctor prescribed avastin and irinotecan for six sessions each taken every two weeks. Tolerance has been relevatly good.
My query is whether is it possible to participate in the these clinical trials after current avastin/ irinotecan?
Contact the clinical trial center closed to you and ask. If they say no, ask about expanded access.
Can this be used just after a patient starts using Optune or is it limited to patients who just completed radiation? How does someone get accepted to clinical trial?
So what is the current progress with this therapy? Does it work?
It looks like it works. It is in the final stages of trials before it can apply for fda approval